To recover your password please fill in your email address
Please fill in below form to create an account with us
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin compared with capecitabine alone in locally advanced rectal cancer.
|
Trial Summary: |
The PETACC6 study is an EORTC-led open-label, randomised, multinational two-arm phase III study investigating whether the addition of oxaliplatin to preoperative fluoropyrimidine-based chemoradiation and postoperative fluoropyrimidine-based chemotherapy improves disease-free survival in locally advanced rectal cancer. |
|
Supported By: |
Cancer Australia; Cancer Council NSW |
|
Eligibility: |
Patients with locally advanced rectal cancer |
|
Registration ID: |
ACTRN12608000403336 |
|
Participation: |
International |
|
Australian Lead Group: |
AGITG |
|
Status: |
closed |
|
Activation Date: |
22/04/2009 |
|
Chairs: |
Hans-Joachim Schmoll (international), Tim Price (Australia) |
|
Contact: |